Bing Center for Waldenstrom's Macroglobulinemia

To display a list of Bing Center Newsletters, please visit our Newsletter Archive.

Articles
Title	Created Date
WM and COVID-19: WMUK Webinar Recordings	01 July 2020
Ixazomib Plus Rituximab and Dexamethasone Safe, Effective for WM	23 June 2020
BeiGene Announces European Medicines Agency Acceptance of its Marketing Authorization Application for BRUKINSA® (Zanubrutinib) for the Treatment of Patients with Waldenström’s Macroglobulinemia	18 June 2020
COVID-19 & Hematologic Malignancies: Patient Experience Update	18 June 2020
Dr. Dimopoulos on the Safety of Zanubrutinib in Waldenström Macroglobulinemia	16 June 2020
BTK Inhibitors for the Treatment of Waldenström Macroglobulinemia	05 June 2020
ASCO 2020 Virtual Meeting	28 May 2020
Video from CBS-4 Boston - Dr. Treon discusses COVID-19 / Ibrutinib Trial	21 May 2020
COVID-19 Information for Our Patients	21 May 2020
Waldenström Macroglobulinemia Specialty Channel	20 May 2020
Dana-Farber to Test Blood Cancer Drug in COVID-19	19 May 2020
BeiGene Announces Clinical and Non-Clinical Data on BRUKINSA™ (Zanubrutinib) and Tislelizumab to Be Presented at the 25th European Hematology Association (EHA) Virtual Congress	18 May 2020
Understanding Waldenström's Macroglobulinemia: A Guide to Diagnosis, Risk Stratification, and Current and Emerging Therapies	17 May 2020
Watch Dr. Jorge Castillo’s engaging “Ask the Doctor” session	14 May 2020
Drs. Castillo and Kastritis have joined the IWMF Scientific Advisory Committee	12 May 2020
Waldenstrom's Song - Tim Salz, UC Berkeley, CA	08 May 2020
Robert J. Manning, FM, RNG	05 May 2020
Presenting 2020 Updated IWMF Publications	03 May 2020
The BTK-inhibitor ibrutinib may protect against pulmonary injury in COVID-19 infected patients	20 April 2020
BeiGene Launching Brukinsa Trial In Later-Stage COVID-19 Patients	18 April 2020

Page 10 of 17